HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
ROCKVILLE, MD and SHENZHEN, CH […]
New it.com Domain Name Goes into Sunrise Phase on 2nd January 2023
London, UK, December 30, 2022 […]
Mazda: Mid-Term Management Plan Update and Management Policy up to 2030
HIROSHIMA, Japan, Nov 22, 2022 […]
80-160 year building use rights in IKN to attract investors: Minister
JAKARTA, Oct 12, 2022 – […]
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
SYDNEY, AU, Sep 6, 2022 – […]
Zhaoke Ophthalmology Announces 2022 Interim Results
HONG KONG, Aug 24, 2022 – […]
Nakamoto Games Entering New Growth Phase
Play-to-earn disruptor to fina […]
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.
HONG KONG, Jun 15, 2022 – […]
Essex Bio-Technology Announces 2021 Financial Results
HONG KONG, Mar 22, 2022 – […]
SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
HONG KONG, Feb 7, 2022 – […]
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
ADELAIDE, AUS, Jan 18, 2022 &# […]
Phase I Clinical Trial of AIM mRNA COVID-19 Vaccine (LVRNA009) Won the Praise of the Industry for High Safety and Well Tolerance
HANGZHOU, CHINA, Jan 12, 2022 […]
Investigational Alzheimer’s Disease Therapy Lecanemab Granted FDA Fast Track Designation
TOKYO, Dec 24, 2021 – (J […]
Why the outcomes of the Glasgow climate talks are key for Singapore
SINGAPORE – The annual U […]
Bit2Me Raises 5 Million Euros as Phase One of ICO Sells Out in Under 60 Seconds
MADRID, Sep 7, 2021 – (A […]